John Colreavy- Enterprise Ireland

    • John Colreavy- Enterprise Ireland's presentations

    Dr. John Colreavy is a Senior Development Advisor within Enterprise Ireland’s Primary Meats & FDI Department. He is responsible for a busy portfolio of leading, developing and emerging meat processing companies in Ireland. John has undertaken a wide range of strategic and developmental scaling projects with companies ranging from small start-up enterprises through to scaling medium sized companies and working with large multi-national businesses. His work is focused on driving growth through export gain, leading to significant job creation. Prior to his current role, he has spent more than twenty seven years serving the application and the commercialisation of research from within academia and industry in the UK and Ireland. He has served time with ICI Paints (ICI Headquarters, London), British Steel (Headquarters Sheffield) and Courtauld’s International (Headquarters Newcastle). Since returning from the UK in 1998, John has served time in the public service with Enterprise Ireland’s Materials Ireland PAT Programme, and then acting as the Director of the Dublin Institute of Technology’s CREST Centre (Surface Engineering), which he established in 2003.  Within CREST, he implemented an ISO 9001 Quality Management System. On joining Enterprise Ireland in 1998, one of his first roles was to undertake the technical study for the European Commission which led to Directive 2004/42/EC governing the solvent content of all architectural paints sold in the 27 EU member states and led the project team responsible for the restoration of the Ha’penny Bridge corrosion protection systems. John initiated the Irish branch of the Institute of Corrosion and acted vice chair of the EU COST action 540 (visible-light-activated photocatalytic materials).  He has had hands-on experience of his own patenting, licensing negotiation, HPSU spin outs, new product development/technical consulting, successful national and trans-national research project acquisition (Irish research calls, EU Framework FP6 & FP7 programmes and U.S. NSF), in addition to the publication of fundamental research.